@article {3952,
	title = {HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment.},
	journal = {Journal of addiction medicine},
	volume = {7},
	year = {2013},
	month = {2013 Nov-Dec},
	pages = {410-6},
	abstract = {We assessed the feasibility and preliminary efficacy of human immunodeficiency virus (HIV) testing with sexual risk reduction counseling for opioid-dependent patients initiating office-based buprenorphine/naloxone treatment.},
	keywords = {Adult, Buprenorphine, Feasibility Studies, Female, HIV Infections, Humans, Male, Naloxone, Narcotic Antagonists, Opiate Substitution Treatment, Opioid-Related Disorders, Patient Education as Topic, Risk Reduction Behavior, Sex Counseling, Sexual Behavior, Treatment Outcome},
	issn = {1932-0620},
	doi = {10.1097/ADM.0b013e3182a3b603},
	author = {Edelman, E Jennifer and Moore, Brent A and Caffrey, Sarah and Sikkema, Kathleen J and Jones, Emlyn S and Schottenfeld, Richard S and Fiellin, David A and Fiellin, Lynn E}
}
